Submitted by ja607 on
Title | Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Xu, M, Yao, Y, Chen, H, Zhang, S, Cao, S-M, Zhang, Z, Luo, B, Liu, Z, Li, Z, Xiang, T, He, G, Feng, Q-S, Chen, L-Z, Guo, X, Jia, W-H, Chen, M-Y, Zhang, X, Xie, S-H, Peng, R, Chang, ET, Pedergnana, V, Feng, L, Bei, J-X, Xu, R-H, Zeng, M-S, Ye, W, Adami, H-O, Lin, X, Zhai, W, Zeng, Y-X, Liu, J |
Journal | Nat Genet |
Volume | 51 |
Issue | 7 |
Pagination | 1131-1136 |
Date Published | 2019 Jul |
ISSN | 1546-1718 |
Abstract | Epstein-Barr virus (EBV) infection is ubiquitous worldwide and is associated with multiple cancers, including nasopharyngeal carcinoma (NPC). The importance of EBV viral genomic variation in NPC development and its striking epidemic in southern China has been poorly explored. Through large-scale genome sequencing of 270 EBV isolates and two-stage association study of EBV isolates from China, we identify two non-synonymous EBV variants within BALF2 that are strongly associated with the risk of NPC (odds ratio (OR) = 8.69, P = 9.69 × 10 for SNP 162476_C; OR = 6.14, P = 2.40 × 10 for SNP 163364_T). The cumulative effects of these variants contribute to 83% of the overall risk of NPC in southern China. Phylogenetic analysis of the risk variants reveals a unique origin in Asia, followed by clonal expansion in NPC-endemic regions. Our results provide novel insights into the NPC endemic in southern China and also enable the identification of high-risk individuals for NPC prevention. |
DOI | 10.1038/s41588-019-0436-5 |
Alternate Journal | Nat. Genet. |
PubMed ID | 31209392 |
PubMed Central ID | PMC6610787 |
Grant List | R35 CA197449 / CA / NCI NIH HHS / United States U19 CA203654 / CA / NCI NIH HHS / United States R01 CA115873 / CA / NCI NIH HHS / United States P01 CA134294 / CA / NCI NIH HHS / United States U01 HG009088 / HG / NHGRI NIH HHS / United States |